AU4337979A - Stabilized prostaglandin composition - Google Patents

Stabilized prostaglandin composition

Info

Publication number
AU4337979A
AU4337979A AU43379/79A AU4337979A AU4337979A AU 4337979 A AU4337979 A AU 4337979A AU 43379/79 A AU43379/79 A AU 43379/79A AU 4337979 A AU4337979 A AU 4337979A AU 4337979 A AU4337979 A AU 4337979A
Authority
AU
Australia
Prior art keywords
prostaglandin composition
stabilized prostaglandin
stabilized
composition
prostaglandin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43379/79A
Inventor
Thomas Cavanak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU4337979A publication Critical patent/AU4337979A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AU43379/79A 1978-01-17 1979-01-15 Stabilized prostaglandin composition Abandoned AU4337979A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH46378 1978-01-17
CH46378 1978-01-17

Publications (1)

Publication Number Publication Date
AU4337979A true AU4337979A (en) 1979-07-26

Family

ID=4187587

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43379/79A Abandoned AU4337979A (en) 1978-01-17 1979-01-15 Stabilized prostaglandin composition

Country Status (20)

Country Link
JP (1) JPS54110313A (en)
AR (1) AR218518A1 (en)
AU (1) AU4337979A (en)
BE (1) BE873481A (en)
DD (1) DD141260A5 (en)
DE (1) DE2900428A1 (en)
DK (1) DK7679A (en)
ES (1) ES476857A1 (en)
FI (1) FI790043A (en)
FR (1) FR2414336A1 (en)
GB (1) GB2012168A (en)
GR (1) GR72910B (en)
IL (1) IL56435A0 (en)
IT (1) IT7947665A0 (en)
NL (1) NL7900255A (en)
NO (1) NO790059L (en)
NZ (1) NZ189380A (en)
PT (1) PT69073A (en)
SE (1) SE7900124L (en)
ZA (1) ZA79199B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3024676A (en) * 1958-11-28 1962-03-13 Sack Gmbh Maschf Hydraulic presses
US4211793A (en) * 1979-03-19 1980-07-08 American Cyanamid Company Triethyl citrate solutions of PGE-type compounds
US4310543A (en) * 1980-10-09 1982-01-12 Hoffmann-La Roche Inc. Prostaglandin compositions
CH651756A5 (en) * 1982-02-05 1985-10-15 Sandoz Ag PHARMACEUTICAL IN THE FORM OF A SUSPENSION CONTAINING THIORIDAZINE.
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
JPS60116628A (en) * 1983-11-29 1985-06-24 Teijin Ltd Composition of pharmaceutical preparation of 7- thiaprostaglandin e1
JPS60169430A (en) * 1984-02-14 1985-09-02 Teijin Ltd Composition for prostaglandin preparation
JPS6191136A (en) * 1984-10-09 1986-05-09 Teijin Ltd Composition for prostaglandin preparation
JPS61289034A (en) * 1985-06-17 1986-12-19 Teijin Ltd Fatty emulsion of prostaglandin i2
JPH04342530A (en) * 1991-04-26 1992-11-30 Teijin Ltd 7-fluoroprostacyclin fatty emulsion
US8614255B2 (en) * 2007-08-21 2013-12-24 Civitas Therapeutics, Inc. Pulmonary pharmaceutical formulations

Also Published As

Publication number Publication date
DE2900428A1 (en) 1979-07-19
ZA79199B (en) 1980-08-27
NO790059L (en) 1979-07-18
FR2414336A1 (en) 1979-08-10
BE873481A (en) 1979-07-16
GB2012168A (en) 1979-07-25
AR218518A1 (en) 1980-06-13
NL7900255A (en) 1979-07-19
ES476857A1 (en) 1979-05-16
IT7947665A0 (en) 1979-01-17
DD141260A5 (en) 1980-04-23
IL56435A0 (en) 1979-03-12
JPS54110313A (en) 1979-08-29
FI790043A (en) 1979-07-18
SE7900124L (en) 1979-07-18
FR2414336B1 (en) 1981-07-31
NZ189380A (en) 1981-01-23
DK7679A (en) 1979-07-18
PT69073A (en) 1979-02-01
GR72910B (en) 1984-01-04

Similar Documents

Publication Publication Date Title
AU528892B2 (en) Polymer-polyol compositions
AU530454B2 (en) Prostaglandin vasodilators
AU4344579A (en) Nitro-bromo-alkanol compositions
AU536416B2 (en) Prostacyclin analogs
AU526954B2 (en) Penicillin composition
AU5165479A (en) Substituted 1-thia-3-aza-4-ones
AU4337979A (en) Stabilized prostaglandin composition
AU529330B2 (en) Piperazinylbenzoheterocyclic compounds
AU526183B2 (en) Sulfonato-organosilanol compounds
AU4432679A (en) Substituted 2-phenylimino-imidazolidines
AU530789B2 (en) Amoxycillin composition
AU528403B2 (en) Flukicidal compounds
AU536516B2 (en) Novel compounds of the muramyl-peptide type
AU4678379A (en) Substituted aklanyl-azolyl oxime-carbamates
AU522799B2 (en) Prostaglandin analogs
AU4807079A (en) Prostaglandin analogues
AU4369979A (en) Substituted n-acyl-amino-tetrahydro-2-furanones
AU530738B2 (en) Fasciolicidal compositions
AU520081B2 (en) Furonaphthyridine compounds
AU4532279A (en) Substituted n-iminomethylpiperidines
AU524104B2 (en) Stabilized prostaglandin e composition
AU4879379A (en) Substituted 2-phenylamino-2-imidazolines
AU519080B2 (en) Prostaglandin analogs
AU531535B2 (en) Oxothia compounds
AU528243B2 (en) Fungicidal composition